QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-neutral-on-treace-medical-concepts-lowers-price-target-to-585

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...

 jp-morgan-downgrades-treace-medical-concepts-to-underweight-lowers-price-target-to-5

JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutral to Underweight and lower...

 btig-downgrades-treace-medical-concepts-to-neutral

BTIG analyst Ryan Zimmerman downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Neutral.

 treace-medical-concepts-lowers-fy2025-sales-guidance-from-224000m-230000m-to-211000m-213000m-vs-227083m-est

Treace Medical Concepts (NASDAQ:TMCI) lowers FY2025 sales outlook from $224.000 million-$230.000 million to $211.000 million-$2...

 treace-medical-concepts-q3-eps-026-beats-028-estimate-sales-50214m-beat-49732m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate ...

 truist-securities-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-7

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price ...

 truist-securities-maintains-hold-on-treace-medical-concepts-raises-price-target-to-8

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price ...

 ubs-maintains-neutral-on-treace-medical-concepts-lowers-price-target-to-65

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...

 stifel-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-6

Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $9 to $6.

 treace-medical-concepts-affirms-fy2025-sales-guidance-of-224000m-230000m-vs-227030m-est

Treace Medical Concepts (NASDAQ:TMCI) affirms FY2025 sales outlook from $224.000 million-$230.000 million to $224.000 million-$...

 treace-medical-concepts-q2-eps-028-beats-029-estimate-sales-47387m-beat-47077m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate ...

 treace-medical-concepts-announces-peer-reviewed-publication-of-the-4-year-interim-results-from-its-align3d-multicenter-prospective-study-demonstrating-clinical-and-radiographic-outcomes-of-the-lapiplasty-procedure-in-the-journal-of-foot--ankle-surgery

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION